DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Acura Pharmaceuticals, Inc. (ACUR)
« Back to company indexACUR Chatter Timeline
Stock Ticker for ACUR
Most Active Tweeters for ACUR
| User | Tweets |
|---|---|
| @StockTipRobot | 1 |
Recent Tweets for ACUR
 |
@StockTipRobot Word on the street (but not THE Street) is that now is the time to exit Acura Pharmaceuticals $ACUR #NotRealStockAdvice December 6th 2019, 7:12am |
 |
@fintel_io $ACUR / Acura Pharmaceuticals files form NT 10-Q https://t.co/UeJ9WSKetT November 8th 2019, 11:11pm |
 |
@Stock_News_Now $ACUR: New SEC Filing for ACUR: Form NT 10-Q (No. 0001104659-19-061728): https://t.co/VKx7t15jdx November 8th 2019, 4:11pm |
 |
@StockTexts $ACUR Acura Pharmaceuticals, Inc. SEC Filing: Form NT 10-Q https://t.co/KAdXkIrKB6 November 8th 2019, 4:11pm |
 |
@dakotafinancial Acura Pharmaceuticals $ACUR Shares Cross Below Two Hundred Day Moving Average of $0.24 https://t.co/YAbCRhJ7F3 October 17th 2019, 6:10pm |
 |
@showcase Sold $edz and am no longer heavily shorting the market. Bought $acur based on technicals and am just rolling with… https://t.co/zDh3FBaBnZ October 17th 2019, 4:10pm |
|
@fintel_io $ACUR / Acura Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Financi… https://t.co/4Oh7eTkWwX October 4th 2019, 4:10pm |
 |
@confcalltran Acura Pharmaceuticals Announces First Quarter 2019 Financial Results https://t.co/K1lfqPY5A4 $ACUR October 4th 2019, 4:10pm |
 |
@CSIMarket $ACUR #stock #StockMarket #AcuraPharmaceuticals issued on https://t.co/savSNU1XbB from preceding quarter from $0… https://t.co/MJ0ga6hOel October 2nd 2019, 5:10am |
|
@confcalltran Acura Pharmaceuticals Just Filed Its Quarterly Report: NOTE 14 – NET LOS... https://t.co/5L7PqkoGPX $ACUR October 1st 2019, 4:10pm |
|
@Stock_News_Now $ACUR: New SEC Filing for ACUR: Form 10-Q (No. 0001144204-19-046746): https://t.co/qNkVxDit0A October 1st 2019, 4:10pm |
 |
@StockNewsNow $ACUR Acura Pharmaceuticals Announces First Quarter 2019 Financial Results https://t.co/IJ5tQ1bNXQ October 1st 2019, 11:10am |
 |
@otc_watch_news $ACUR #Pink No Information Acura Pharmaceuticals, Inc. (ACUR: Pink No Information) | Acura Pharmaceuticals Announce… https://t.co/T2vbhlE0G8 October 1st 2019, 6:10am |
 |
@StockWolfCom $ACUR Acura Pharmaceuticals Announces First Quarter 2019 Financial Results https://t.co/TRjgE0kTYm October 1st 2019, 6:10am |
 |
@GNWLive Acura Pharmaceuticals Announces First Quarter 2019 Financial Results $ACUR https://t.co/tlmVKUURns October 1st 2019, 6:10am |
 |
@ThisLincolnian Acura Pharmaceuticals $ACUR Stock Rating Lowered by ValuEngine https://t.co/fJmeC9LnhE September 29th 2019, 1:09am |
 |
@TickerReport Acura Pharmaceuticals $ACUR Rating Lowered to Hold at ValuEngine https://t.co/eDWp5VKwSA September 27th 2019, 1:09am |
 |
@AmericanBanking Head-To-Head Review: Pulmatrix $PULM versus Acura Pharmaceuticals $ACUR https://t.co/WXFAWStg2o #stocks September 26th 2019, 8:09am |
|
@ThisLincolnian Acura Pharmaceuticals $ACUR Stock Price Crosses Below Two Hundred Day Moving Average of $0.22 https://t.co/S5n719ojsP September 17th 2019, 7:09pm |
|
@fintel_io $ACUR / Acura Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Financi… https://t.co/PJeZQc7Cl4 September 17th 2019, 5:09pm |
 |
@marketexclusive $ACUR ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition https://t.co/1QY6aauaNn September 17th 2019, 4:09pm |
|
@confcalltran Acura Pharmaceuticals Announces Fourth Quarter 2018 https://t.co/32mnVnqwMX $ACUR September 17th 2019, 11:09am |
|
@CSIMarket $ACUR #stock #StockMarket #AcuraPharmaceuticals publishes on https://t.co/savSNU1XbB From preceding quarter, from… https://t.co/3RNRCp7RrC September 17th 2019, 5:09am |
|
@StockNewsNow $ACUR Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results https://t.co/Zzg1N0womf September 16th 2019, 6:09pm |
|
@fintel_io $ACUR / Acura Pharmaceuticals files form 10-K https://t.co/UeJ9WSKetT September 16th 2019, 4:09pm |
|
@confcalltran Acura Pharmaceuticals Just Filed Its Annual Report: Basic and Diluted... https://t.co/ITwJOALJ2f $ACUR September 16th 2019, 4:09pm |
|
@Stock_News_Now $ACUR: New SEC Filing for ACUR: Form 10-K (No. 0001144204-19-044723): https://t.co/px2JwSEO6f September 16th 2019, 4:09pm |
 |
@investor_feed $ACUR 10-K Acura Pharmaceuticals (16 Sep, 4:33pm) ? 2018 FY Earnings https://t.co/OmNUn6khby #ACUR #10K… https://t.co/gCjDMepMAg September 16th 2019, 4:09pm |
|
@otc_watch_news $ACUR #Pink No Information Acura Pharmaceuticals, Inc. (ACUR: Pink No Information) | Acura Pharmaceuticals Announce… https://t.co/p8AfwdwfTp September 16th 2019, 4:09pm |
|
@StockWolfCom $ACUR Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results https://t.co/9eLx0bB6r9 September 16th 2019, 4:09pm |
|
@GNWLive Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results $ACUR https://t.co/KyA25udT6s September 16th 2019, 4:09pm |
|
@TickerReport Acura Pharmaceuticals $ACUR Rating Increased to Buy at ValuEngine https://t.co/NddgYSGwuy September 13th 2019, 4:09am |
|
@AmericanBanking Stock Analysts’ Upgrades for September, 10th $ACUR, AIRG, ALDX, ASPU, ATU, AVD, BC, BJRI, BOOT, CULP https://t.co/4i0w2Y4Iug #stocks September 10th 2019, 10:09pm |
 |
@MaisaCorp $ACUR Engaged Catalent Pharma Solutions To Initiate Manufacturing Scale-Up Of LTX-03 Tablets September 9th 2019, 6:09pm |
|
@StockNewsNow $ACUR Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03 https://t.co/TiP6bH7WUj September 9th 2019, 11:09am |
|
@StockWolfCom $ACUR Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03 https://t.co/9tcXh9OFtI September 9th 2019, 6:09am |
|
@StockTexts $ACUR Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03 Other OTC:ACUR https://t.co/5khuzNe80H September 9th 2019, 6:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.